358 related articles for article (PubMed ID: 17196291)
1. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
[TBL] [Abstract][Full Text] [Related]
2. [Transfection and anti-HBV effect mediated by the hepatocytes-targeting cationic liposomes co-modified with beta-sitosterol-beta-D-glucoside and Brij 35].
Zhang Y; Qi XR; Gao Y; Wei L
Yao Xue Xue Bao; 2006 Nov; 41(11):1111-5. PubMed ID: 17262957
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of cytoplasmic delivery by non-cationic liposomes to cells in vitro: a confocal laser scanning microscopy study.
Mady MM; Ghannam MM; Khalil WA; Müller R; Fahr A
Phys Med; 2009 Jun; 25(2):88-93. PubMed ID: 18590977
[TBL] [Abstract][Full Text] [Related]
4. Disaccharide-modified liposomes and their in vitro intracellular uptake.
Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.
Shi J; Yan WW; Qi XR; Maitani Y; Nagai T
Drug Deliv; 2005; 12(6):349-56. PubMed ID: 16253950
[TBL] [Abstract][Full Text] [Related]
6. Modeling cytoplasmic release of encapsulated oligonucleotides from cationic liposomes.
Tamaddon AM; Shirazi FH; Moghimi HR
Int J Pharm; 2007 May; 336(1):174-82. PubMed ID: 17196349
[TBL] [Abstract][Full Text] [Related]
7. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
[TBL] [Abstract][Full Text] [Related]
8. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes.
Tu Y; Kim JS
J Gene Med; 2008 Jun; 10(6):646-54. PubMed ID: 18383507
[TBL] [Abstract][Full Text] [Related]
9. Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry.
Owada T; Matsubayashi K; Sakata H; Ihara H; Sato S; Ikebuchi K; Kato T; Azuma H; Ikeda H
J Viral Hepat; 2006 Jan; 13(1):11-8. PubMed ID: 16364077
[TBL] [Abstract][Full Text] [Related]
10. Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-kappaB-inducing kinase-specific siRNA using liver-targeting liposomes.
Cho HA; Park IS; Kim TW; Oh YK; Yang KS; Kim JS
Arch Pharm Res; 2009 Jul; 32(7):1077-86. PubMed ID: 19641890
[TBL] [Abstract][Full Text] [Related]
11. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
12. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone (T3)-modification of polyethyleneglycol (PEG)-polyethyleneimine (PEI) graft copolymers for improved gene delivery to hepatocytes.
Rudolph C; Sieverling N; Schillinger U; Lesina E; Plank C; Thünemann AF; Schönberger H; Rosenecker J
Biomaterials; 2007 Apr; 28(10):1900-11. PubMed ID: 17196251
[TBL] [Abstract][Full Text] [Related]
14. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
15. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.
Fujiwara T; Akita H; Harashima H
Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779
[TBL] [Abstract][Full Text] [Related]
16. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes.
Letrou-Bonneval E; Chèvre R; Lambert O; Costet P; André C; Tellier C; Pitard B
J Gene Med; 2008 Nov; 10(11):1198-209. PubMed ID: 18816485
[TBL] [Abstract][Full Text] [Related]
17. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.
Fumoto S; Kawakami S; Ito Y; Shigeta K; Yamashita F; Hashida M
Mol Ther; 2004 Oct; 10(4):719-29. PubMed ID: 15451456
[TBL] [Abstract][Full Text] [Related]
18. Gene delivery into hepatocytes with the preS/liposome/DNA system.
Wang Z; Yuan Z; Jin L
Biotechnol J; 2008 Oct; 3(9-10):1286-95. PubMed ID: 18830969
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting.
Bernardes GJ; Kikkeri R; Maglinao M; Laurino P; Collot M; Hong SY; Lepenies B; Seeberger PH
Org Biomol Chem; 2010 Nov; 8(21):4987-96. PubMed ID: 20820666
[TBL] [Abstract][Full Text] [Related]
20. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.
Remaut K; Lucas B; Braeckmans K; Demeester J; De Smedt SC
J Control Release; 2007 Feb; 117(2):256-66. PubMed ID: 17188777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
